Cardiac conduction disease is a serious disorder and the leading cause of mortality worldwide[@b1]. Conduction slowing of the electric impulse may result in syncope and sudden cardiac death (SCD)[@b2][@b3]. The human voltage-gated cardiac sodium channel generates the initial fast upstroke of the action potentials. Mutations in *SCN5A*, the gene that encodes the pore-forming subunit of human cardiac sodium channel Nav1.5, have been associated with a variety of inherited arrhythmogenic syndromes including type 3 long-QT syndrome (LQT3)[@b4], Brugada syndrome (BrS)[@b5], progressive cardiac conduction disease (PCCD)[@b6], sick sinus syndrome (SSS)[@b7], atrial fibrillation (AF)[@b8], dilated cardiomyopathy (DCM)[@b9] and more complex overlapping syndrome[@b10][@b11].

There is a rapid growing interest for clinical diagnosis of the disease genes that underlie genetic heart rhythm disorders since the discovery of the first Long QT type 3 syndrome-associated genes in 1995[@b4][@b12], As mentioned, a collection of cardiac diseases are caused by a single channelopathy gene *SCN5A*. Alternatively, 13 distinct disease-causing genes are implicated in a single OMIM entity, the conduction system disease[@b13], suggesting a more complex genetic heterogeneity than previously thought. The high genetic heterogeneity, variable expressions, reduced penetrance and pleiotropic effects of arrhythmias-related genes have impeded the identification of pathogenic gene[@b14][@b15][@b16], especially for channelopathies with rare clinical phenotypes.

In the present study, we investigated a clinically characterized family with a history of CCD, syncope and sudden cardiac death. An obvious autosomal-dominant inheritance with discordant cardiac abnormalities (e.g. conduction disease, congenital heart disease and bradyarrhythmias) has been observed in this family. Since congenital heart diseases (CHD), especially tetrology of Fallot (TOF), have been rarely reported in channelopathies, we hypothesize that this family might represent a new variant or an uncharacterized inherited cardiac channelopathy. By whole-exome sequencing of four family members (three affected and one normal control), we identified a novel nonsense mutation Y1495X in *SCN5A* that might underlie this unique inherited cardiac arrhythmia.

Methods
=======

Patients and subjects
---------------------

The study protocol was approved by the Review Board of the Second Xiangya Hospital of the Central South University in China, and the study participants gave informed consent. All experiments were performed in accordance with relevant guidelines and regulations. We enrolled 37 members of this family (10 affected, 25 unaffected and 2 unknown) in the study. Blood were obtained from the affected probands and family members. Subjects were reviewed by medical records including 12-lead echocardiogram (ECG), ultrasonic cardiogram (UCG) and hospital records. PR, QRS interval, QT, QTc duration and QRS axis were measured. The normal range of the ECG measurements was based on the age of each individual. For adult, a QRS interval \> 100 ms and a PR interval \> 210 ms were considered prolonged[@b17].

DNA extraction
--------------

Genomic DNA was extracted from peripheral blood lymphocytes of the family members. Genomic DNA was prepared using a DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA) on the QIAcube automated DNA extraction robot (Qiagen, Hilden, Germany) as previously described[@b18].

Targeted Capture and Massive Parallel Sequencing
------------------------------------------------

Exome capture and high-throughput sequencing (HTS) were performed in the State Key Laboratory of Medical Genetics of China (SKLMG) in collaboration with Beijing Genomics Institute (BGI Shenzhen)[@b19]. Five micrograms of genomic DNA from 4 family members (three affected, II-3, III-10, IV-1 and one normal control, III-14) were captured with the NimbleGen SeqCap EZ library exome capture reagent (Roche Inc., Madison, USA) and sequenced (Illumina Hiseq2000, 90 base-paired end reads) (Illumina Inc, San Diego, USA). Briefly, genomic DNA was randomly fragmented by Covaris S2 instrument (Covaris, Inc., Woburn, USA). Then the 250--300 bp fragments of DNAs were subjected to three enzymatic steps: end repair, A-tailing and adapters ligation. Once the DNA libraries were indexed, they were amplified by ligation-mediated PCR. Extracted DNA was purified and hybridized to the NimbleGen SeqCap EZ Library. Each captured library was then loaded to the Illumina Hiseq2000 platform. Illumina base calling software v1.7 was employed to analyze the raw image files with default parameters.

Reads, Mapping and Variant detection
------------------------------------

SNP analysis was performed as previously described[@b20]: (i) Reads were aligned to the NCBI human reference genome (gh19/NCBI37.1) with SOAPaligner method v2.21; (ii) for paired-end reads with duplicated start and end sites, only one copy with the highest quality was retained, and the reads with adapters were removed; (iii) SOAPsnp v1.05 was used to assemble the consensus sequence and call genotypes;(iv) small indel detection was used with the Unified Genotyper tool from GATK v1.0.4705.

Filtering and Annotation
------------------------

Four major steps were taken to prioritize all the high-quality variants[@b20]: (a) variants within intergenic, intronic, and UTR regions and synonymous mutations were excluded from later analysis; (b) variants in dbSNP132 (<http://www.ncbi.nlm.nih.gov/projects/SNP/>), the 1000 Genomes project (1000G,[www.1000genomes.org](http://www.1000genomes.org)), and HapMap Project (<ftp://ftp.ncbi.nlm.nih.gov/hapmap>) were excluded; (c) Variants in YH Database (<http://yh.genomics.org.cn/>) and NHLBI Exome Sequencing Project (ESP) database (<http://evs.gs.washington.edu/EVS/>) were further excluded; (d) SIFT (<http://sift.bii.astar.edu.sg/>), Polyphen2 (<http://genetics.bwh.harvard.edu/pph2/>), MutationTaster ([www.mutationtaster.org](http://www.mutationtaster.org)) and GERP (UCSC Genome Browser) were used to predict the possible impacts of variants.

Mutation Validation and Co-segregation Analysis
-----------------------------------------------

Sanger sequencing was used to validate the candidate variants found in whole-exome sequencing. Segregation analyses were performed in the family members. Primers pairs used to amplify fragments encompassing individual variants were designed using an online tool (PrimerQuest, IDT) (<http://www.idtdna.com/Primerquest/Home/Index>), and the sequences of the primers are listed in [Supplementary Table S1](#s1){ref-type="supplementary-material"}.

Results
=======

Clinical features
-----------------

We identified a Chinese family with multiple complex phenotypes including conduction diseases, CHD and sudden cardiac death ([Fig. 1A](#f1){ref-type="fig"}). The proband (III-10), a 48-year-old farmer from Hunan province of Central-South China, had a syncope during rest after hard manual labor. He had no record of symptom for almost 40 years since his first syncope at seven years old. Physical examination showed a congenital heart disease (tetrology of Fallot, TOF) and cardiac conduction disease ([Fig. 1B, C](#f1){ref-type="fig"}). Family history examination showed his mother died at 35 years old during sleep for unknown reason. One of the proband\'s maternal uncles also died during sleep at 37 years old. Due to a high risk of surgical correction for adult TOF and conduction disease, the proband was discharged without surgery. Currently, he is in a stable condition.

Eight family members, along with the proband, had a history of syncope. We recruited all family members for further physical examination with ECG and UCG. Family member II-3, II-8, III-8, III-10, III-18 and IV-1 had a prolonged QRS without CHD ([Table 1](#t1){ref-type="table"}). The son of the proband (IV-4) had sinus bradycardia with a heart rate of 37 (beats/min) and a prolonged PR interval (202 ms) ([Table 1](#t1){ref-type="table"}).

Genetic analysis
----------------

Because CHD is rarely reported in arrhythmias, we postulated that this pedigree may represent a rare undescribed inherited cardiac channelopathy. To identify the underlying genetic cause, genomic DNA samples of four participants of the family, including the proband (III-10), his affected uncle II-3, the grandson of the affected uncle (IV-4) and his unaffected maternal sister (III-14), were analyzed by WES ([Fig. 2A](#f2){ref-type="fig"}). For the four samples, WES yielded an average of 10 Gb data with an appropriately 95% coverage of target region and a 93% of target covered over 10× ([Table 2](#t2){ref-type="table"}).

The detected SNV and INDELs were analyzed by multiple filter strategies. After alignment and SNV calling, 85,738 variants were present in the exome of the proband ([Table 2](#t2){ref-type="table"}). After exclusion of shared common variants present in dbSNP132, 1000 Genomes Project and BGI in-house control (2500 exomes) as well as ESP database, 765 unique SNPs were identified ([Table 2](#t2){ref-type="table"}). Variants shared by three affected family members (II-3, III-10 and IV-1) but not present in the unaffected normal control (III-14) were identified, in which 32 rare variants were further analyzed ([Supplementary Table S2](#s1){ref-type="supplementary-material"}).

Of the 32 variants, 15 were ranked using three different bioinformatic programs ([Supplementary Table S3](#s1){ref-type="supplementary-material"}) and chosen as the candidates for pathogenicity of this unique family. Sanger DNA sequencing was employed to examine the mutation segregated with affected members (PCR primers are listed in [Supplementary Table S3](#s1){ref-type="supplementary-material"}), which indicates that a novel nonsense 1495× mutation in *SCN5A* as the underlying genetic lesion of these patients ([Fig. 2](#f2){ref-type="fig"}).

To explore the etiology of CHD in the proband by known genetic mutation, we focused on the 765 remaining variants of the proband and revised our strategy with a filter of 456 CHD-related genes ([Supplementary Table S4](#s1){ref-type="supplementary-material"}). The single patient analysis excluded the possibility of a known causative gene that underlie CHD.

Discussion
==========

In this study, we employed whole-exome sequencing to explore the possible causative gene for a family with overlap syndrome including CHD, conduction diseases and sudden cardiac death and identified a novel nonsense mutation in codon 1495 of *SCN5A*. The mutation locates in the highly conserved triad IFM motif (formed by residues 1485--1487)[@b21] and is predicted to result in a premature protein truncation that is closely associated with channelopathies. Our study is consistent with previous reports that nonsense mutations cause more severe phenotypes in humans as well as animal models[@b22][@b23][@b24][@b25].

Whole-exome sequencing (WES) has developed into a powerful and cost-effective tool to uncover genetic basis for rare Mendelian diseases[@b26][@b27]. WES also shows tremendous potential in genetic diagnostics that helps to expand the clinical spectrum of known diseases[@b28][@b29][@b30]. However, one of the major challenges in WES is to discriminate the pathogenic variants from the benign ones[@b31][@b32]. Several strategies with different filters have been developed to exclude variants that are unlikely to cause disease. Recently WES coupling with bioinformatics method in cardiovascular genetic study leads to the identification of *CACNA1C* in Long QT syndrome[@b33]. Based on a similar strategy, we revised the filter strategy to a tetra-overlapping filer, which resulted in a significant decrease of candidate genes (32 genes) in our study and is an obvious improvement over the 110 candidate genes of the triangulation strategy in the aforementioned study[@b33].

The cause of the CHD in the proband of the family is unclear. Channelopathies (LQT3 and BS) are often found with a structurally normal heart. However there have been a few reports about the links between ion channel gene *SCN5A* mutation and CHD[@b15]. In 2002, Bezzina *et al* reported a small muscular ventricular septal defect (VSD) in the index patient of a familial conduction disease harboring co-occurrence mutations (W156X and R225W)[@b34]. Recently, an Ebstein\'s anomaly was reported in a German boy with severe conduction disease carrying a homozygous mutation (I230T)[@b35]. CHDs are also observed in individuals carrying mutations in other channelopathy disease-causing genes. For example, Timothy Syndrome (LQT8, mutated in *CACNA1C*) is reported to have multiple anomalies including congenital heart diseases (e.g. tetralogy of Fallot)[@b36]. We have excluded known CHD genes as the underlying genetic causes. However it remains a possibility, though rare, that the CHD phenotype (TOF) is caused by an unidentified genetic mutation as described by "the second hit model"[@b37][@b38].

Our result suggests that the nonsense mutation (Y1495X) in *SCN5A* might be the causal genetic lesion of multiple overlap syndromes including conduction disease, sudden death and CHD in a single family, reinforcing the previously speculated mechanistic link between cardiac channelopathies and overlap syndromes[@b38][@b39]. In addition, the CHD patient (TOF) carrying this mutation may offer a valuable chance to examine the relationship between TGF-β1 mediated fibrosis, aging processes and *SCN5A* in human heart, a possibility suggested by recent findings in Scn5a knockout animal models[@b23][@b40][@b41][@b42]. Since the correction of TOF needs an open-heart surgery, we might be able to observe the exact evidence during the procedure of the surgery, likely an unprecedented study for channelopathy diseases. Open-heart surgery of TOF usually requires excision of large amount of cardiac papillary muscle in order to discharge the right ventricular outflow tract obstruction (RVOTs), which might offer an exciting alternative for cellular electrophysiological study with primary cardiac cells, an experiment currently performed only with induced pluripotent stem cell-derived (iPS) cardiomyocytes[@b43][@b44].

Conclusions
===========

Using whole-exome sequencing in combination with bioinformatics analyses, we identified the nonsense mutation (Y1495X) in *SCN5A* as a possible cause of overlap syndrome including CHD, conduction diseases and sudden cardiac death in a Chinese family. Our study suggests that this approach will facilitate our understanding of the etiology of this rare type of arrhythmias by effective identification of the causative gene mutations and should promote the diagnosis and treatment of these diseases.
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![Clinical features of family members with conduction diseases.\
(A) Electrocardiograms (ECGs) of the family members (II-3, III-8, IV-1, IV-4) and the proband (III-10). (B) Ultrasonic cardiogram (UCG) of proband shows cardiac structural defect, tetralogy of Fallot (TOF). (C) Computed tomography (CT) of the proband\'s heart shows a pulmonary hypoplasia.](srep05616-f1){#f1}

![Whole exome sequencing and familial genomic tetra-overlapping for the identification of a novel genetic variant for multiple complex syndromes.\
(A) Pedigree of the family. Black circles/squares are affected, white are unaffected. Arrow indicates the proband. 4 large circles (3 in red and 1 in blue) represent the 4 individuals underwent whole exome sequencing. Plus signs indicate Y1495 *SCN5A* mutation positive. Minus signs indicate mutation-negative. NA represents DNA samples were not available. (B) Overlapping filter strategy. Asterisks denotes remaining variants for further analysis that are present in 3 affected members (red circles) but not in the normal control (blue circle). (C) Sanger DNA sequencing chromatogram demonstrates the heterozygosity for a *SCN5A* mutation (p.Y1495X, c.4485C \> A). (D) Schematic representation of the filter strategies employed in our study.](srep05616-f2){#f2}

###### Demographic and electrocardiographic features in members of the family

                                                                                                                                                              ECG intervals (ms)                                          
  -------------------------------------- --- -------------------------------- --------------- ----------------------------------------------- ----- -------- -------------------- -------------- --------- -------------- ----
  II-1                                    M                 76                 Asymptomatic                         no                         −2      83          190(210)          82(100)      368/432                  \-
  II-3[\*](#t1-fn3){ref-type="fn"}        M                 72                 Syncope(\>20)   Sinus bradycardia, LAFB, T wave abnormalities   −67   **50**      **256**(210)      **144**(100)   446/418                  \+
  II-5                                    F   35 [†](#t1-fn4){ref-type="fn"}      Syncope                           NA                         NA      NA             NA                NA          NA      Sudden death   NA
  II-7                                    M   37 [†](#t1-fn4){ref-type="fn"}      Syncope                           NA                         NA      NA             NA                NA          NA      Sudden death   NA
  II-8                                    F                 64                 Syncope(\>10)                       RBBB                        −65   **52**      **244**(210)      **140**(100)   438/426                  \+
  III-6                                   M                 39                   3syncopes                         RBBB                                61          208(210)        **134**(100)   430/432                  \+
  III-8                                   M                 35                  3 syncopes                         RBBB                        268     74          168(210)        **172**(100)   422/468                  \+
  III-10[\*](#t1-fn3){ref-type="fn"}\#    M                 48                  3 syncopes          Sinus bradycardia, first degree AVB        254   **54**      **284**(210)      **142**(100)   446/434    CHD (TOF)     \+
  III-14[\*](#t1-fn3){ref-type="fn"}      F                 46                 Asymptomatic                         no                         42      82          138(210)           80(90)      370/432                  −
  III-18                                  M                 30                  2 syncopes                         RBBB                        14      56          204(210)        **138**(100)   434/434                  \+
  IV-1[\*](#t1-fn3){ref-type="fn"}        M                 8                    1 syncope                         LAFB                        −41     75          148(170)         **92**(90)    382/426                  \+
  IV-2                                    F                 5                  Asymptomatic                         no                         42     124          128(170)           62(90)      306/439                  −
  IV-4                                    M                 18                  2 syncopes                   Sinus bradycardia                 74    **37**      **202**(180)        96(100)      454/383                  \+

NA = not available; QTc = corrected QT interval; RBBB = Right Bundle Branch Block; LAFB = Left anterior fascicular block. AVB = atrioventricular Block; CHD = congenital heart disease; TOF = tetralogy of Fallot.

\+ Y1495X present, − Y1495X absent.

\*Whole- exome sequenced.

^†^Age of death.

\#Index case.

###### Summary of SNPs for exome captured samples and filter procedure

  Categories                                                                                                   III-10[\*](#t2-fn1){ref-type="fn"}     II-3        IV-1      III-14 (control)
  ----------------------------------------------------------------------------------------------------------- ------------------------------------ ----------- ----------- ------------------
  **Exome Capture Statistics**                                                                                                                                                      
  Target region (bp)[(1)](#t2-fn2){ref-type="fn"}                                                                           62085286                61988644    62085286        62085286
  Raw reads                                                                                                                 92737976                138497858   145426084      139851618
  Raw data yield (Mb)                                                                                                         9465                    11149       11707          11258
  Reads mapped to genome                                                                                                    93894979                140334153   147846058      142256214
  Reads mapped to target region[(2)](#t2-fn3){ref-type="fn"}                                                                53479844                82582631    87924642        82990685
  Data mapped to target region (Mb)                                                                                         3677.14                  5658.73     6019.33        5690.76
  Coverage of target region (%)                                                                                              95.68                    95.93       95.69          95.84
  Average read length (bp)                                                                                                    80.5                    80.5        80.51           80.5
  Fraction of target covered \> = 10X (%)                                                                                    93.27                    94.02       93.93          93.96
  Fraction of target covered \> = 20X (%)                                                                                     89.6                    91.86       91.83          91.76
  Fraction of target covered \> = 30X (%)                                                                                    81.92                    88.12       88.16          87.88
  **SNPs for exome capture**                                                                                                                                                        
  No. high-confidence genotypes                                                                                            115744429                115676179   113537889      114980456
  Total number of SNPs                                                                                                       85738                    91309       89061          89972
  Missense                                                                                                                   11032                    11352       11127          11269
  Nonsense                                                                                                                    127                      144         143            143
  Splice site[(3)](#t2-fn4){ref-type="fn"}                                                                                    2498                    2675        2651            2682
  Synonymous-coding                                                                                                           9600                    9934        9792            9894
  Hom                                                                                                                        36615                    37234       37483          37668
  Het                                                                                                                        49123                    54075       51578          52304
  Novel variants                                                                                                                                                                    
  Number not in dbSNP                                                                                                         1287                    1373        1358            1241
  Number not in 1000 Genome and YH                                                                                            765                      787         779            755
  Missense                                                                                                                    624                      631         632            610
  Nonsense                                                                                                                     15                      21          23              19
  Splice site                                                                                                                 126                      135         124            126
  No. of genes presented in 3 affected patients but not in the normal family member III-14                                     32                                          
  Top-ranked detrimental effect of variants by three distinct programs (Polyphen2, SIFT and MutationTaster)                    15                                          
  No. of validated variants co-segregating with affected members                                                               1                                           
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\*Index patient.

(1)Target regions refer to the regions that are actually covered by the designed probes.

(2)Reads mapped to target regions are reads that within or overlap with target region.

(3)Intronic SNPs within 10 bp of exon/intron boundary.
